new glp-1 drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Doctor Reveals The MOST POWERFUL

CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days

NO added synthetic flavourings, (often labeled as Natural Flavourings),NO soy,NO citric acid, NO alcohol

Pure Tested Peptides is not a compounding / chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act

GLP-1 Receptor Agonists May Reduce Rheumatoid Arthritis Activity and Cardiovascular Risk in People with Obesity Key Takeaways: GLP-1 receptor agonists were linked to reduced rheumatoid arthritis (RA) disease activity and improved cardiovascular risk factors in people with obesity or overweight